Conference Secretariat: InfoPlus Events LLC, United Arab Emirates, Tel: +971 4 4218996, [email protected], www.InfoPlusEvents.com 9 th ANNUAL CASE BASED APPROACH TO CONTROVERSIES IN CARDIOVASCULAR DISEASES March 1 st - 2 nd , 2019 Mohammed Bin Rashid Academic Medical Center Dubai Healthcare City, Dubai, UAE www.CVUAE.com #CVUAE | #IPEvents CONFERENCE BOOK TITANIUM SPONSOR GOLD SPONSOR MAIN SPONSOR PLATINUM SPONSORS CME ACCREDITED BY ORGANIZED BY APPROVED BY
Transcript
Conference Secretariat: InfoPlus Events LLC, United Arab Emirates, Tel: +971 4 4218996, [email protected], www.InfoPlusEvents.com
9th ANNUALCASE BASED
APPROACH TOCONTROVERSIES IN
CARDIOVASCULARDISEASES
March 1st - 2nd, 2019Mohammed Bin Rashid
Academic Medical CenterDubai Healthcare City, Dubai, UAE
www.CVUAE.com#CVUAE | #IPEvents
CONFERENCE BOOKTITANIUM SPONSORGOLD SPONSORMAIN SPONSOR PLATINUM SPONSORS CME ACCREDITED BY ORGANIZED BYAPPROVED BY
Course Directors
US Organizing Committee
Joseph Maalouf, MDProfessor of MedicineMayo Clinic College ofMedicine ConsultantCardiovascular Diseases andInternal Medicine DirectorInterventional EchocardiographyMayo Clinic, RochesterMinnesota, USA
Course Directors & Committees
Walid Saliba, MDStaff, Section ofCardiac Electrophysiologyand Pacing Department ofCardiovascular MedicineHeart and Vascular InstituteOhio, USA
Katherine Hoercher, RNSenior DirectorHeart and Vascular InstituteOhio, USA
Wael Jaber,MDStaff, Section ofCardiovascular ImagingDepartment of CardiovascularMedicine and Vascular InstituteOhio, USA
Join the conversation at #CVUAE Your input matters! www.CVUAE.com 3
Wael AdbulrahmanAl Mahmeed, MDConsultant Cardiologist at theHeart and Vascular InstituteAbu Dhabi, UAE
Faculty
Cleveland Clinic
Katherine Hoercher, RNSenior Director, Heart andVascular InstituteOhio, USA
Venu Menon, MDStaff, Section of CardiovascularImaging, Department of Cardiovascular MedicineHeart and Vascular InstituteOhio, USA
Oussama Wazni, MDStaff, Section of CardiacElectrophysiology and PacingDepartment of CardiovascularMedicine Heart andVascular InstituteOhio, USA
Wael Jaber,MDStaff, Section ofCardiovascular ImagingDepartment of CardiovascularMedicine, Heart and Vascular InstituteOhio, USA
Walid Saliba, MDStaff, Section ofCardiac Electrophysiologyand Pacing Department ofCardiovascular MedicineHeart and Vascular InstituteOhio, USA
Mayo Clinic
Daniel Borgeson, MDAssistant Professor of MedicineMayo Clinic College ofMedicine and ScienceConsultant for Department ofCardiovascular MedicineOhio, USA
Amy Pollak MDAssistant Professor of MedicineMayo Clinic College of MedicineConsultant, CardiovascularDiseases and Internal MedicineMayo ClinicJacksonville, Florida, USA
Faisal Bakaeen, MDStaff, Department of Thoracicand Cardiovascular SurgeryHeart and Vascular InstituteOhio, USA
Brian Griffin, MDSection Head, CardiovascularImaging Department ofCardiovascular MedicineHeart and Vascular InstituteOhio, USA
Peter Pollak MDSenior Associate ConsultantInvasive and InterventionalCardiology Mayo ClinicJacksonville, Florida, USA
Join the conversation at #CVUAE Your input matters!www.CVUAE.com4
Joseph Maalouf, MDProfessor of MedicineMayo Clinic College ofMedicine ConsultantCardiovascular Diseases andInternal Medicine DirectorInterventional EchocardiographyMayo Clinic, RochesterMinnesota, USA
Faculty
Cleveland Clinic Abu Dhabi
Wael AdbulrahmanAl Mahmeed, MDConsultant Cardiologist at theHeart and Vascular InstituteAbu Dhabi, UAE
Bassam Atallah, Pharm DM.S., BCPS-AQ Cardiology, FHFSAPharmacotherapySpecialist-CardiologyDepartment of Pharmacy Services Heart Failure Society of AmericaMiddle East AmbassadorCleveland Clinic Abu DhabiAbu Dhabi, UAE
Khalid Al Muti, MDConsultant PhysicianCardiac Electrophysiology &Cardiovascular DiseaseAbu Dhabi, UAE
Feras Bader, MDClinical AssociateProfessor of MedicineDirector, Section ofHeart Failure and TransplantHeart & Vascular InstituteChairman, Heart FailureWorking Group ofEmirates Cardiac SocietyAbu Dhabi, UAE
Ahmad Edris, MDConsultant PhysicianAbu Dhabi, UAE
Dima Quraini, MDStaff physician at the Heartand Vascular Institute atCleveland ClinicAbu Dhabi, UAE
Mohammed Khalil, MDClinical Assistant ProfessorCleveland Clinic Lerner Collegeof Medicine of CaseWestern Reserve UniversityDirector of Imaging &Clinical ServicesHeart and Vascular InstituteCleveland Clinic Abu DhabiAbu Dhabi, UAE
Hussein Saadi, MDChair, Medical SubspecialtiesInstitute, Clinical Professorof Medicine Cleveland ClinicAbu Dhabi, UAE
Hani Sabbour, MDStaff Physician in the Heartand Vascular Institute atCleveland ClinicAbu Dhabi, UAE
Murat Tuzcu, MDProfessor of MedicineChief Academic OfficerChairman, Heart andVascular InstituteChairman, Department of Cardiovascular MedicineAbu Dhabi, UAE
Join the conversation at #CVUAE Your input matters! www.CVUAE.com 5
Faculty
Regional and Local
Bernard Abi Saleh, MDCardiac ElectrophysiologyAmerican University ofBeirut Faculty of Medicineand Medical CenterLebanon
Jumaa Al DhaheriConsultant InvasiveAdult CardiologyChief of MedicineZayed Military HospitalAbu Dhabi, UAE
Safaa Al Mohdar, MDDubai, UAE
Mohamed Al Jaabari, MDConsultant CardiologistSheikh Khalifa Medical CityAbu Dhabi, UAE
Obaid Al Jassim, MDConsultant CardiothoracicSurgeon, Dubai HospitalDubai, UAE
Fahad Al Sindi, MDConsultant Heart FailureCardiologist, Mohd BinKhalifa Cardiac CenterBahrain
Sultan Al Karam, MDChief Medical OfficerTawam HospitalDubai, UAE
Abdulmajid Al Zubaidi, MDDubai, UAE
Walid Alami, MDInterventional CardiologistLebanon
Ghaliah Almohany, MDSenior Consultant interventionaland Electrophysiologist,National Heart InstituteMuscat, Oman
Join the conversation at #CVUAE Your input matters!www.CVUAE.com6
Hussain Ismaeel, MDAssociate Professor ofClinical MedicineDirector, VascularMedicine ProgramDivision of CardiologyAmerican University of Beirut Lebanon
Moutaz El Kadri, MDConsultant cardiologist andElectrophysiologistSheikh Khalifa Medical CityDubai, UAE
Adel Khalifa, MDConsultant Cardiologist &Interventional CardiacElectrophysiologistHead of Electrophysiology DepartmentBahrain
Marwan Refaat, MDAssociate Professor of Medicineand BiochemistryInternal MedicineBiochemistry & Molecular GeneticsDirector, CardiovascularFellowship ProgramMember, Division of CardiologySection of Cardiac ElectrophysiologyLebanon
Join the conversation at #CVUAE Your input matters! www.CVUAE.com 7
First Day - Friday 1st March, 2019
Scientific Program
08:00 - 08:20 Registration and Coffee
Session I: Transcatheter Valvular Therapies: Patient Selection and Outcomes Panel: Ahmad Edris, Faisal Bakaeen,Obaid Al Jassim, Juma Al Dhaheri, Bassam Atallah
08:30 - 09:50
Welcome and Opening Remarks08:20 - 08:30
Session II: Prevention and Management of HTN and DyslipidemiaPanel: Amy Pollak, Hanni Sabbour ,Joseph Maalouf
09:50 - 10:10 Coffee Break
15:20 - 15:40 Coffee Break
12:20 - 13:30 Lunch and Friday Prayer
08:30 - 08:50 Brian GriffinPeter Pollak
Bassam Attallah
Amy Pollak
Adel KhalifaGhalia Al Mohanni
Walid Saliba
Hussain Ismaeel
08:50 - 09:10Patient with functional MR: Surgery versus ClipPatient with failed mitral bioprosthesisMorbidly Obese Patient post TAVR with MS and AF:Choosing antithrombotic therapy
09:10 - 09:30
Peter Pollak09:30 - 09:50 Low Risk Patient with AS: TAVR or SAVR
10:10 - 10:30 The Healthy patient with hypertension:Would you do a calcium score test?
Walid Saliba11:50 - 12:20
Latest Update on AF Managements.Where does theevidence lead us 2019
10:50 - 11:20 Industry Symposium
11:20 - 11:50 Industry Symposium
Industry Symposium
10:30 - 10:50 PCSK9: does it affect cognition? Good for everyone?
In HF Management, The Sooner The Better Feras BaderChairman: Wael Almahameed
13:30 - 13:50 47 year old patient with AFib and LA clot13:50 - 14:10 75 year old female with high CHADSVASC score and GI bleeding
Oussama Wazni14:30 - 14:50 60 year old with LV dysfunction and AF
Stroke Prevention in AFIb Khalid Almutti14:50 - 15:20 Industry Symposium
14:10 - 14:30 65 year old patient with LV dysfunction,VF and AF post CABG
Venu Menon
Venu Menon
Amy Pollak
15:40 - 16:00 47 year old man with type 2 diabetes and recent acutecoronary syndrome presents for an office visit
16:00 - 16:20 Myocardial infarction with non-obstructive coronaryarteries in a patient with diabetes
16:20 - 16:40 54 year old man with diabetes and strong family historypresents for an outpatient consultation
10:10 - 10:50
Session III: Focus on AF ManagementPanel: Khalid Almuti, Marwan Refaat, Mohamad Magdi, Hosam Zaky,Mohamed Al Jaabari
13:30 - 15:30
Session IV: CV Risk Stratification and Management in DiabeticsPanel: Noosheen, Hussein Saadi, Joseph Maalouf
15:40 - 16:40
Session V: EKG: Read with the ExpertsPanel: Walid Saliba, Venu Menon, Oussama Wazni
16:40 - 17:20
COMPASS TRIAL: Exploring Vascular Protection in patientswith CAD or PAD through potential of factor Xa inhibition
Venu Menon
Second Day - Saturday 2nd March, 2019
Scientific Program
Join the conversation at #CVUAE Your input matters! www.CVUAE.com 9
08:00 - 09:00 Registration and Welcome Coffee
Session VI: Focus: on Myocardial Revascularization in the setting of CADPanel: Murat Tuzcu, Wael Jaber, Faisal Baakeen,Obaid Al Jassim,Abdulmajid Al Zubaidi, Sultan Alkaram
09:00 - 10:00
Session VII: Gender Differences in Diagnosis and Management of CVDPanel: Nooshin Bazargani, Dima Quraini , Juwairiah Tahir,Safa Almohdar Wael Almahmeed, Feras Bader
10:00 - 10:20 Coffee Break
15:15 - 15:40 Coffee Break
12:00 - 13:15 Lunch Break
09:00 - 09:20 Venu MenonPeter PollakWael Jaber
Amy Pollak
Dan Borgenson
Fahad Alsindi
09:20 - 09:40Support devices in AMI and shockCoronary disease and TAVR: treat or leave alone?
09:40 - 10:00 67 year old male with CAD and EF of 28%; Value ofIschemia/hibernation testing to determinevalue of revascularization
10:20 - 10:40 Patient with Postpartum cardiomyopathy
11:20 - 11:55 Industry Symposium
10:40 - 11:00 Patient with SCAD
Amy PollakPCSK9 inhibitors
Brian Griffin11:00 - 11:20 MV disease in female planning a pregnancy
13:15 - 13:35 73 year old male with increasing shortness of breath andrepeated hospitalizations
Dan BorgensonFahad Alsindi
13:55 - 14:1564 year old male with new LV dysfunction and severe MR13:35 - 13:5565 year old female with new onset LBBB and HF
Oussama Wazni
Hani SabbourBernard Abi Saleh
14:15 - 14:30 62 year old with new onset syncope and VF arrest14:30 - 14:45 21 year old with palpitations and NSVT on Holter
Walid Saliba15:00 - 15:15 56 year old physician with Cardiac Mass
14:45 - 15:00 67 year old man with severe lower extremitycellulitis VF storm
10:20 - 11:20
Session VIII: Focus on Heart FailurePanel: Feras Bader, Dan Borgenson, Nooshin Bazargani, Mohammed Khalil,Bassam Atallah
13:15 - 14:15
Session IX: Focus on Ventricular arrhythmiasPanel: Khalid Al Muti, Ghalia Almohany, Mohammad Khalil, Adel Khalifa,Walid Saliba, Motaz Kadri
14:15 - 15:15
Session X: Read with the Experts : Imaging InterpretationsPanel: Wael Jaber, Joe Maalouf, Venu Menon, Brian Griffin, Mohammad Khalil
References: 1. Granger C, Alexander J, McMurray J,et al. Apixaban versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med.2011; 365(11): 981-992., 2. Agnelli G, Buller H, Cohen A, et al. Oral Apixaban for the Treatment of Acute Venous Thromboembolism. N Engl J Med. 2013; 369(9):799-808., 3. Eliquis Local Product Document. Version Date Feb. 17, V1 for Qatar, and Kuwait and Version Date Dec.17 for UAE,Oman, and Bahrain.
Full prescribing information is available upon request
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversi-fied portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. In 2016, the Group achieved net sales of USD 48.5 billion, while R&D throughout the Group amounted to approximately USD 9.0 billion. Novartis Group companies employ approximately 121,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world.
Website: www.novartis.com
Novartis
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions. With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
Website: www.sanofi.com
Sanofi
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products.
Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world.
Website: www.pfizer.com
Pfizer
SponsorsGold Sponsor
Platinum Sponsors
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technolo-gies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and produc-tion, to liquid crystals for smartphones and LCD televisions. Founded in 1668, Merck is the world's oldest pharmaceutical and chemical compa-ny. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
Website: www.merck.ae
Merck
Titanium Sponsor
Join the conversation at #CVUAE Your input matters! www.CVUAE.com 11
C
M
Y
CM
MY
CY
CMY
K
The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 145 affiliates and a total of around 47,500 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.
Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects, such as the initiative “Making more Health” and caring for the employees. Respect, equal opportunities and reconciling career and family form the foundation of the mutual cooperation. In everything it does, the company focuses on environmental protection and sustainability.
Website: www.boehringer-ingelheim.com
AmgenAmgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its manufacturing expertise to strive for solutions dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be the world’s largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential
Website: www.amgen.com
EXHIBITORS
Boehringer Ingelheim
Bayer is an innovation company with a more than 150-year history and core competencies in the fields of health care and agriculture. We develop new molecules for use in innovative products and solutions to improve the health of humans, animals and plants. Our research and development activities are based on a profound understanding of the biochemical processes in living organisms. An analysis by well-known branding agency Interbrand in 2015 valued the Bayer brand at €6.3 billion. Our goal is to achieve and sustain leadership positions in our markets, thus creating value for our customers, stockholders and employees. To this end, our strategy is designed to help solve some of the most pressing challenges facing mankind, and by doing this exceptionally well we aim to strengthen the company’s earning power.
Website: www.middleeast.bayer.com
Bayer
Sponsors and ExhibitorsSupport Sponsors
Exhibitor
Join the conversation at #CVUAE Your input matters!www.CVUAE.com14
CME & Useful Information
Join the conversation at #CVUAE Your input matters! www.CVUAE.com 15
CME Information:• This Conference is CME accredited with 13.25 CME Credit Hours by Ministry of Health And Prevention.• Please scan your badge every time you enter to the conference Hall.• CME Certificates can be obtained starting March 12th, 2019, through the Conference website: www.CVUAE.com• Delegates should log in using the registration number on their badge.• Fill the evaluation form and you will be able to download your certificate.• Kindly use Laptop/Desktop computers to download the certificates.• The deadline to download the Certificate is April 30th, 2019.
Food & Beverage:• Coffee break will be open to registered delegates.• Meal will be offered against the voucher provided with the delegate badges.• There is an ATM machine conveniently located next to the elevators in the forum venue.• The conference venue is a non-smoking venue. Participants are requested to visit designated smoking corners when smoking is desired.
Regulations:• Mobile Phones: As courtesy to the other delegates, please ensure that your mobile phone is switched to silent while in the main room.
Parking:• Paid parking is available at the venue.
Internet Access:• Wi-fi Internet access is available in all public areas in the forum Venue.Internet connection: DHCA-GuestUsername: dhccPassword: DHCC@123
EVACUATION ASSEMBLY POINT: In case of an emergency evacuation procedure please proceed in an orderly fashion to the venue main entrance. Please follow the instructions of the venue Staff at all times.
February 28th & 29th, 2020
See you
Next Year
The Organizing Committee would like to express its gratitude to the followingcompanies for their unconditional support to this activity
